DURECT to Present at Merriman Curhan Ford’s Annual Investor Summit

Download PDF:

CUPERTINO, Calif., Sept. 11 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that Felix Theeuwes, Chairman and CSO, will
present at the 4th annual Merriman Curhan Ford & Co. Investor Summit on
September 17, 2007 at 11:45 a.m. Pacific Time. This event will be held at the
Mark Hopkins InterContinental Hotel in San Francisco. More information about
the conference can be found at: http://www.merrimanco.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations.”
If you are unable to participate during the live webcast, the call will be
archived on DURECT’s website under Audio Archive in the “Investor Relations”

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit

CONTACT: Matthew J. Hogan, Chief Financial Officer, +1-408-777-4936, for
DURECT Corporation
Web site: http://www.www.durect.com

Scroll to Top